Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
PBM Capital
CharlottesvilleSeries A–Late Stage
6 people
Percipient Capital
LondonSeed–Late Stage$1.3M – $6.3M
3 people
Rapha Capital Management, LLC
SurfsideSeed–Series A
1 person
BioFrontier Partners, Inc.
TokyoSeries A–Late Stage$500K – $3M
11 people
Improve Ventures
BarcelonaPre-Seed–Series A$100K – $1M
5 people
NewMargin Ventures
ShanghaiPre-Seed–Series B$500K – $5M
5 people
QB Capital
FukuokaPre-Seed–Series A
8 people
Top Harvest Capital
Menlo ParkPre-Seed–Series A
5 people
Venture
ZurichPre-Seed–Series B
8 people
EMBL Ventures
HeidelbergSeed–Series A$108K – $5.4M
2 people
Israel Innovation Authority
JerusalemPre-Seed–Growth
2 people
Bridford Investments (Bridford Group)
LondonSeed–Growth
1 person
Cambridge Capital Group
CambridgePre-Seed–Series A$10K – $2M
1 person
Eastend Ventures
AdelaidePre-Seed–Series A
4 people
HARPER COURT VENTURES
ChicagoPre-Seed–Series A
4 people
Excell Partners
RochesterPre-Seed–Series A$100K – $1.5M
3 people
Hermann Hauser Investment
InnsbruckSeed–Series A
6 people
4see Ventures
Chêne-BougeriesPre-Seed–Series A$432K – $1.1M
2 people
Buff Gold Ventures
BoulderPre-Seed–Series A
3 people
Mizuho Capital
TokyoPre-Seed–Growth
1 person
Radar Ventures
Pre-Seed–Series A
1 person
Phyto Partners
Boca RatonSeed–Series A
2 people
INP Capital
VancouverSeed–Late Stage
6 people
Dynamk Capital
New YorkSeed–Series B
4 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.






























































